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Summary
INTRODUCTION: Several studies have shown an in-
creased risk of type 2 diabetes among smokers. Therefore,
the aim of this analysis was to assess the relationship
between smoking, cumulative smoking exposure and nicot-
ine dependence with pre-diabetes.
METHODS: We performed a cross-sectional analysis of
healthy adults aged 25–41 in the Principality of Liecht-
enstein. Individuals with known diabetes, Body Mass In-
dex (BMI) >35 kg/m2 and prevalent cardiovascular disease
were excluded. Smoking behaviour was assessed by self-
report. Pre-diabetes was defined as glycosylated haemo-
globin between 5.7% and 6.4%. Multivariable logistic re-
gression models were done.
RESULTS: Of the 2142 participants (median age 37 years),
499 (23.3%) had pre-diabetes. There were 1,168 (55%)
never smokers, 503 (23%) past smokers and 471 (22%)
current smokers, with a prevalence of pre-diabetes of
21.2%, 20.9% and 31.2%, respectively (p <0.0001). In
multivariable regression models, current smokers had an
odds ratio (OR) of pre-diabetes of 1.82 (95% confidential
interval (CI) 1.39; 2.38, p <0.0001). Individuals with a
smoking exposure of <5, 5–10 and >10 pack-years had an
OR (95% CI) for pre-diabetes of 1.34 (0.90; 2.00), 1.80
(1.07; 3.01) and 2.51 (1.80; 3.59) (p linear trend <0.0001)
compared with never smokers. A Fagerström score of 2,
3–5 and >5 among current smokers was associated with an
OR (95% CI) for pre-diabetes of 1.27 (0.89; 1.82), 2.15
(1.48; 3.13) and 3.35 (1.73; 6.48) (p linear trend <0.0001).
DISCUSSION: Smoking is strongly associated with pre-
diabetes in young adults with a low burden of smoking ex-
posure. Nicotine dependence could be a potential mechan-
ism of this relationship.
Key words: Pre-diabetes; haemoglobin A1c; smoking;
nicotine dependence; risk factors
Introduction
Cigarette smoking is a leading cause of avoidable morbid-
ity and mortality worldwide [1]. In a recent study, tobacco
smoking alone accounted for 6.3% of all global disability-
adjusted life-years [1]. Accordingly, both male and female
smokers lose at least 10 years of lifespan compared to nev-
er smokers [2–5]. A better understanding on how smoking
relates to death and other adverse events is therefore of ma-
jor public health importance.
Several studies have shown a strong relationship between
cigarette smoking and type 2 Diabetes mellitus (T2D), in-
dependent of other diabetes related risk factors [6–13].
Similar to smoking, T2D is also one of the most important
risk factors for global disease burden [1]. Thus, a pro-dia-
betic effect could be a potential mediator for some of the
adverse effects of smoking, but the causality of this rela-
tionship has not been well established [8], and its under-
lying mechanisms are poorly understood. Differences in
physical activity and body composition, especially fat dis-
tribution, could be involved [13, 14]. A recent study also
suggested that genetic polymorphisms in the nicotinic acet-
ylcholine receptor genes may contribute to the occurrence
of insulin resistance and T2D, raising the intriguing pos-
sibility that nicotine dependence may be mechanistically
involved in the relationship between smoking and T2D as
well [15].
Furthermore, little information is available on the time
course of the relationship between smoking and T2D. De-
monstrating an association between smoking and pre-dia-
betes, i.e., elevations in blood glucose levels that do not yet
fulfill the criteria of T2D among young individuals would
support this to be an early effect, and would underscore
the importance of primary smoking prevention and early
smoking cessation. However, few studies have been per-
formed in this context [8]. Finally, controversial data have
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been published on the effect of smoking cession on the oc-
currence of T2D [10–12].
Therefore, the aim of this analysis was to assess the rela-
tionship between smoking, cumulative smoking exposure
and nicotine dependence with pre-diabetes in a large, well-
characterised sample of young and healthy adults from the
general population.
Methods
The genetic and phenotypic determinants of blood pressure
and other cardiovascular risk factors (GAPP) study is a
population-based cohort study from the Principality of
Liechtenstein. Details about recruitment and study meth-
odology have been published previously [16]. In brief,
between 2010 and 2013, all inhabitants of the Principality
of Liechtenstein aged 25–41 years, namely 6887 individu-
als, were invited to participate in this study. 5775 indi-
viduals could be contacted by phone and were eligible. A
study flow chart is provided in (fig. 1). Main exclusion
Figure 1
Recruitment of the GAPP cohort study. Flow chart of the
recruitment of the GAPP study.
Figure 2
Relationship of pre-diabetes with cumulative smoking exposure.
Never smokers represent the reference group. Boxes indicate odds
ratios, whiskers are 95% confidence intervals. Data are adjusted for
age, sex, Body Mass Index, hypertension, alcohol consumption,
education, low density lipoprotein and high density lipoprotein
cholesterol, physical activity, fruit/vegetable consumption and body
composition.
criteria were known cardiovascular disease, renal failure,
known sleep apnoea syndrome, current intake of antidia-
betic drugs, any other major illness, and a Body Mass Index
(BMI) >35 kg/m2. Up to December 2013, 2170 participants
have been included in GAPP (participation rate of 38%).
13 participants (0.6%) with missing HbA1c levels, 3 with
missing smoking status (0.1%) and 12 participants (0.3%)
with HbA1c levels >6.4% were excluded from the current
analysis, leaving 2142 participants. The study protocol was
approved by the local ethics committee. Informed written
consent is obtained from each participant.
Assessment of smoking
Details about smoking history were obtained by question-
naire. Current smoking was defined as answering yes to the
question “Do you currently smoke”. Participants were clas-
sified as past smokers if they reported active smoking in
the past but not currently. Past smokers also indicated the
year of smoking cessation. The remaining participants who
did not report smoking currently or in the past were classi-
fied as never smokers. Pack-years of smoking were calcu-
lated by multiplying the number of years smoked by the av-
erage number of cigarette packs smoked per day. We used
the validated Fagerström questionnaire to quantify nicot-
ine dependence among current smokers [17]. The Fager-
ström questionnaire includes the following six questions
about smoking behaviour: (1) “When do you smoke your
first cigarette after getting up?”, (2) “Is it difficult for you
to not smoke in places where smoking is prohibited?”,
(3) “Which cigarette would you be least willing to give-
up?”, (4) “How many cigarettes do you generally smoke
per day?”, (5) “Do you generally smoke more in the morn-
ing than during the rest of the day?”, (6) “Is it the case
that you smoke even though you are so ill that you have
to spend most of the day in bed?”. Based on these ques-
tions, a score between 0 and 10 is obtained, with higher
scores indicating stronger dependence to nicotine. Second-
hand smoke exposure of all individuals was quantified us-
ing three questions about exposition to secondhand smoke
at home, in restaurants or bars and at the workplace. If one
of the three questions was answered with ”yes”, the dura-
tion of exposure was also obtained.
Pre-diabetes
Pre-diabetes was defined as glycated haemoglobin (HbA1c)
between 5.7% and 6.4%, as recommended by the current
guidelines of the American Diabetes Association [18].
HbA1c was measured with a standardised assay from fast-
ing venous blood samples using high performance liquid
chromatography (Bio-Rad D-10, Bio-Rad Laboratories
AG, Switzerland).
Other study variables
Information about personal, lifestyle, medical and nutri-
tional factors was obtained by questionnaire. Height,
weight and office blood pressure were measured in a stand-
ardised manner using validated devices, as described pre-
viously [16]. BMI was calculated as body weight in kilo-
grams divided by height in meters squared. Hypertension
was defined as mean systolic blood pressure of 140, mean
diastolic blood pressure 90 and/or intake of blood pressure
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lowering drugs. Physical activity was assessed with the
validated individual physical activity questionnaire (IPAQ)
[19]. Regular physical activity for the current analysis was
defined as >180 min of vigorous activity per week. Regular
consumption of fruits and/or vegetables was defined as 5
servings per day. Body composition (percent of fat mass,
muscle mass and body water) was measured using bioelec-
trical impedance analysis. Lipid levels were measured from
fasting venous blood samples using standard methodology
(Roche Cobas 6000, F. Hoffmann – La Roche, Switzer-
land).
Statistical analyses
Baseline characteristics were compared according to the
presence or absence of pre-diabetes. The normality of the
distribution for continuous variables was checked using
skewness, kurtosis and visual inspection of the histogram.
Normally distributed variables were compared using t-
tests, otherwise we used Wilcoxon rank sum tests. Categor-
ical variables were compared by Chi-square tests.
Multivariable logistic regression models were constructed
to compare odds ratios (OR) and 95% confidence intervals
(CI) for pre-diabetes among current, past and never
smokers, and to adjust for potential confounders. Age and
sex adjusted models were further adjusted for BMI, hy-
pertension, alcohol consumption, low density lipoprotein
cholesterol, high density lipoprotein cholesterol, education,
physical activity, dietary factors and body composition
variables. To evaluate the effect of long term tobacco ex-
posure and to assess a potential dose-response relationship,
a similar series of regression models was constructed using
the number of pack-years as predictor of interest according
to three pre-defined categories: <5, 5–10 and >10 pack-
years.
To assess the relationship between nicotine dependence
and prediabetes, we divided current smokers into three pre-
defined groups based on the Fagerström test score (2, 3–5
and >5) [20, 21]. As the number of pack-years smoked is
part of this questionnaire, we repeated the analyses using a
modified scale that does not include the question about cu-
mulative smoking burden (maximum score 7; ≤1,2-3, ≥4),
in order to evaluate whether the obtained findings were in-
dependent of the cumulative tobacco exposure. We then
evaluated whether the relationship between smoking and
pre-diabetes may be potentially reversible by comparing
the odds of pre-diabetes according to whether past smokers
had stopped smoking <2 years, 2–4 years or >4 years be-
fore baseline examination [11]. Again, multivariable mod-
els were constructed as detailed above.
For all the above mentioned logistic regression analyses
participants who never smoked were the reference group.
The effect of secondhand smoke on pre-diabetes was as-
sessed by comparing the odds of prediabetes among those
with and without any exposure to secondhand smoke and
by comparing the prevalence according to approximate ter-
tiles of secondhand smoke exposure in similar multivari-
able logistic regression models.
Categorical variables were entered in the multivariable
models using binary indicator variables. Tests for linear
trend were performed using category-specific median val-
ues. All statistical analyses were performed using SAS
version 9.2 (SAS Institute Inc, Cary, North Carolina). A
p-value <0.05 was pre-specified to indicate statistical sig-
nificance.
Results
Median age of the 2142 participants was 37 years and 47%
of the participants were male. The proportion of current,
past and never smokers in the overall sample was 22%,
23% and 55%, respectively. Baseline characteristics strati-
fied by the presence or absence of pre-diabetes are shown
in table 1. Individuals with pre-diabetes (n = 499, 23.3%)
were significantly older, more often male and they had a
significantly higher BMI compared with those without pre-
diabetes. Individuals with pre-diabetes also had a higher
prevalence of current smokers, higher blood pressure levels
and worse lipid profiles compared with normoglycemic in-
dividuals. Furthermore, smokers with pre-diabetes had a
significantly higher lifetime tobacco exposure (5.5 versus
11.3 pack-years, p <0.0001).
The prevalence of pre-diabetes was 31.2%, 20.9% and
21.2% among current, past and never smokers, respectively
Figure 3
Relationship of pre-diabetes with time since smoking cessation.
Never smokers represent the reference group. Boxes indicate odds
ratios, whiskers are 95% confidence intervals. Data are adjusted for
age, sex, Body Mass Index, hypertension, alcohol consumption,
education, low density lipoprotein and high density lipoprotein
cholesterol, physical activity, fruit/vegetable consumption and body
composition.
Figure 4
Relationship between nicotine dependence and pre-diabetes Data
are with (left side) and without (right side) including information on
cumulative smoking exposure into the score. Never smokers
represent the reference group. Boxes indicate odds ratios, whiskers
are 95% confidence intervals adjusted for age, sex, Body Mass
Index, hypertension, alcohol consumption, education, low density
lipoprotein and high density lipoprotein cholesterol, physical activity,
fruit/vegetable consumption and body composition.
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(p <0.0001). These results were confirmed in multivariable
logistic regression analyses, as shown in table 2. In the un-
adjusted model, the OR of pre-diabetes for current smoking
was 1.69 (95% CI 1.33; 2.15, p <0.0001) compared with
never smokers. Multivariable adjustment, based on data
of 2107 participants (due to missing values) only slightly
changed this relationship, such that in the fully adjusted
model, the OR for current smokers became 1.82 (95% CI
1.39; 2.38, p <0.0001). Past smokers did not have an in-
creased odds of pre-diabetes compared with never smokers
(fully adjusted OR 0.96 (95% CI 0.73; 1.26, p = 0.75).
Dose response relationships using pack-years of smoking
are shown in table 3 and (fig. 2). A cumulative smoking
exposure of <5, 5–10 and >10 pack-years was associated
with a crude OR (95% CI) of 1.05 (0.73; 1.53), 1.67 (1.03;
2.71) and 2.60 (1.89; 3.61), respectively (p for linear trend
<0.0001). Again, this relationship was only minimally af-
fected by multivariable adjustment, such that the fully ad-
justed ORs (95% CI) were 1.34 (0.90; 2.00), 1.80 (1.07;
3.01) and 2.51 (1.80; 3.59), respectively (p for linear trend
<0.0001).
Among past smokers, there was an inverse linear relation-
ship between time since smoking cessation and prevalen-
ce of pre-diabetes (p for linear trend <0.0001), as shown
in table 4 and (fig. 3). While none of the individual rel-
ative risk estimates was statistically significant, these data
nevertheless suggest that the prevalence of pre-diabetes is
similar to that of never smokers after at most four years of
smoking cessation.
Results of the association between Fagerström scores and
pre-diabetes among current smokers are shown in table
5 and (fig. 4). Compared with never smokers, current
smokers with a Fagerström score ≤2, 3–5 and >5 had an
unadjusted OR (CI 95%) for pre-diabetes of 1.18 (0.84;
1.64), 1.90 (1.35; 2.67) and 3.47 (1.88; 6.41), respectively.
Adding potential confounders had a minimal influence on
this relationship, the fully adjusted OR (CI 95%) for these
three groups being 1.27 (0.89; 1.82), 2.15 (1.48; 3.13) and
3.35 (1.73; 6.48), respectively (p for linear trend <0.0001).
These results were very similar when the question about
cumulative smoking exposure was excluded from the
Fagerström questionnaire, as shown in table 5 and figure 4.
Table 1: Baseline characteristics according to the presence or absence of pre-diabetes.
N = 2142 Normoglycaemia
N = 1643 (76.7)
Pre-diabetes
N = 499 (23.3)
p1
Male sex (%) 735 (44.7) 272 (54.5) 0.0001
Age, years 36 (31; 40) 38 (33; 41) <0.0001
Height, cm 172 ± 9 173 ± 9 0.10
Weight, kg 72.2 ± 14.6 75.9 ± 14.8 <0.0001
Body Mass Index, kg/m2 24.3 ± 3.7 25.4 ± 4.0 <0.0001
Smoking (%) <0.0001
Current 324 (19.7) 147 (29.5)
Past 398 (24.2) 105 (21.0)
Never 921 (56.1) 247 (49.5)
Pack-years2 5.5 (3.5; 13.5) 11.3 (4.5; 17.25) <0.0001
Highest education level achieved (%) 0.27
High school degree 128 (7.9) 47 (9.5)
Hollege degree 923 (57.0) 291 (59.0)
University degree 568 (35.1) 155 (31.4)
Regular consumption of fruits/vegetables (%) 306 (18.6) 106 (21.2) 0.19
Daily alcohol consumption (g/24 hours) 0.64 (0.00; 1.71) 0.64 (0.00; 2.01) 0.47
Physical activity (%) 788 (48.0) 282 (56.5) 0.0008
Fat mass (%) 25 ± 6 25 ± 7 0.44
Muscle mass (%) 35 ± 4 36 ± 4 0.08
Body water (%) 54 ± 5 54 ± 6 0.82
Systolic BP, mm Hg 120 ± 13 122 ± 13 <0.0001
Diastolic BP, mm Hg 78 ± 9 79 ± 9.0 0.007
Hypertension (%) 211 (12.8) 81 (16.2) 0.05
LDL Cholesterol, mmol/l 2.89 ± 0.81 3.22 ± 0.94 <0.0001
HDL Cholesterol, mmol/l 1.55 ± 0.41 1.47 ± 0.42 0.0001
Data are presented as mean ± SD, median (interquartile range) or number (percentage). N = 30 missing information on education.
1 P values were based on t-tests, Wilcoxon rank sum tests or Chi-square tests, as appropriate
2 Among current smokers
Table 2: Multivariable logistic regression analysis of the relationship between smoking and pre-diabetes.






Unadjusted model Ref. 0.98 (0.76; 1.27) 1.69 (1.33; 2.15)
Age and sex adjusted model Ref. 0.96 (0.74; 1.24) 1.80 (1.41; 2.31)
Fully adjusted model1 Ref. 0.96 (0.73; 1.26) 1.82 (1.39; 2.38)
Data are odds ratios (95% confidence intervals)
1 Adjusted for sex, age, Body Mass Index, hypertension, alcohol consumption, low density lipoprotein cholesterol, high density lipoprotein cholesterol, education, physical
activity, fruit/vegetable consumption and body composition; 2107 participants included
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The fully adjusted OR for exposure to any secondhand
smoke was 1.00 (95% CI 0.93; 1.08) compared with never
smokers. Among individuals indicating an exposure to
secondhand smoke of <1, 1–2 and >2 hours per day, the
multivariable adjusted ORs (95% CI) were 0.97 (0.68;
1.39), 0.92 (0.48; 1.78) and 1.00 (0.60; 1.68), respectively.
Discussion
In this large population based sample of young and healthy
individuals, we found that current smoking was strongly
associated with pre-diabetes. Compared with never
smokers, participants currently smoking cigarettes had an
OR for pre-diabetes of 1.82 (95% CI 1.39; 2.38) even after
adjustment for multiple confounders and potential mediat-
ors. We also found a linear risk gradient across categories
of cumulative smoking exposure. Even a cumulative ex-
posure to as few as 5–10 pack-years was associated with
a highly significant OR (95% CI) for pre-diabetes of 1.80
(1.07; 3.01). These data therefore are in line with previous
studies showing an association between smoking and T2D
[6–10].
In addition, this is one of the first investigations in younger
individuals with a shorter exposure to environmental risk
factors and a lower cumulative smoking exposure. For ex-
ample, in a prior population based study in an older pop-
ulation the cumulative smoking exposure was 2–3 times
higher than in the current analysis [10]. Our data therefore
suggest that glucose disturbances among smokers is a relat-
ively early phenomenon, as has been suggested previously
[6]. Accordingly, a prior experimental study showed that
cigarette smoking directly decreased insulin action and in-
creased insulin resistance [22]. In line with this potential
direct effect, none of the various covariates introduced in
the multivariable models changed the strength of the rela-
tionship between smoking and pre-diabetes. Because prior
studies hypothesised on a possible role of body composi-
tion and low socioeconomic status in this association, the
lack of effect of these variables is particularly noteworthy
[8, 13, 14]. In contrast to prior studies on this issue [23,
24], we did not see a relationship between education level
Table 3: Multivariable logistic regression analysis between pre-diabetes and pack-years of smoking.
Current smokers N = 4711











Unadjusted model Ref. 0.98 (0.76; 1.27) 1.05 (0.73; 1.53) 1.67 (1.03; 2.71) 2.60 (1.89; 3.61) <0.0001
Age and sex adjusted model Ref. 0.96 (0.74; 1.24) 1.31 (0.89; 1.93) 1.78 (1.09; 2.91) 2.40 (1.72; 3.33) <0.0001
Fully adjusted model2 Ref. 0.96 (0.74; 1.26) 1.34 (0.90; 2.00) 1.80 (1.07; 3.01) 2.51 (1.80; 3.59) <0.0001
Data are odds ratios (95% confidence intervals).
1 N = 14 with missing information on pack-years
2 Adjusted for past smoking, sex, age, Body Mass Index, hypertension, alcohol consumption, low density lipoprotein cholesterol, high density lipoprotein cholesterol,
education, physical activity, fruit/vegetable consumption and body composition; 2093 participants included.
Table 4: Multivariable logistic regression analysis between pre-diabetes and time since smoking cessation.
Past smokers N = 5031













p for linear trend
Unadjusted model Ref. 1.69 (1.33; 2.15) 1.55 (0.95; 2.53) 1.01 (0.54; 1.89) 0.85 (0.63; 1.51) <0.0001
Age and sex adjusted model Ref. 1.82 (1.42; 2.33) 1.71 (1.04; 2.84) 1.25 (0.66; 2.38) 0.77 (0.57; 1.05) <0.0001
Fully adjusted model2 Ref. 1.85 (1.41; 2.42) 1.69 (0.99; 2.88) 1.26 (0.64; 2.43) 0.79 (0.57; 1.08) <0.0001
Data are odds ratios (95% confidence intervals)
1 N = 6 with missing information on time since smoking cessation.
2 Adjusted for current smoking, sex, age, Body Mass Index, hypertension, alcohol consumption, low density lipoprotein cholesterol, high density lipoprotein cholesterol,
education, physical activity, fruit/vegetable consumption and body composition; 2102 participants included.
Table 5: Multivariable logistic regression analysis between pre-diabetes and Fagerström scores.
Current smokers N = 4711













p for linear trend
Unadjusted model Ref. 0.96 (0.74; 1.24) 1.18 (0.84; 1.64) 1.90 (1.35; 2.67) 3.47 (1.88; 6.41) <0.0001
Age and sex adjusted model Ref. 0.93 (0.72; 1.21) 1.32 (0.94; 1.86) 1.99 (1.40; 2.82) 3.22 (1.72; 6.01) <0.0001













p for linear trend
Unadjusted model Ref. 0.98 (0.76; 1.27) 1.29 (0.92; 1.81) 1.77 (1.22; 2.57) 2.61 (1.66; 4.11) <0.0001
Age and sex adjusted model Ref. 0.96 (0.74; 1.24) 1.44 (1.01; 2.04) 1.85 (1.27; 2.71) 2.67 (1.68; 4.25) <0.0001
Fully adjusted model2 Ref. 0.96 (0.73; 1.26) 1.39 (0.97; 2.00) 2.01 (1.35; 3.01) 2.90 (1.76; 4.77) <0.0001
Data are odds ratios (95% confidence intervals).
1 N = 28 with missing information for normal Fagerström score calculation and N = 27 with missing information for adapted Fagerström score calculation.
2 Adjusted for past smoking, sex, age, Body Mass Index, hypertension, alcohol consumption, low density lipoprotein cholesterol, high density lipoprotein cholesterol,
education, physical activity, fruit/vegetable consumption and body composition; 2107 participants included.
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and prevalent prediabetes, as shown in table 1. A potential
explanation for this lack of association could be the high
overall socio-economic status in the Principality of Liecht-
enstein, and different results may be observed in popula-
tions with a larger socio-economic spread.
A second novel observation of our study was that higher
scores of the Fagerström questionnaire, a well validated
tool of nicotine dependence [17], were strongly associated
with pre-diabetes in this study, even after exclusion of cu-
mulative smoking exposure from the score. These data sug-
gest that the nicotinergic system and nicotine dependence
may play a role in smoking related hyperglycaemia, which
is in line with a small experimental study showing that the
long-term use of nicotine containing chewing gums was as-
sociated with insulin resistance and hyperinsulinemia [25].
Furthermore, the majority of inhaled nicotine is catabolised
into cotinine by an enzymatic activity, which is mediated
by CYP2A6. Liu et al. have shown that heavy smokers with
a slow or poor metabolizer genotype were more suscept-
ible to develop T2D compared to heavy smokers with a fast
metabolizer genotype [26]. Finally, a recent study sugges-
ted that genetic polymorphisms within the nicotinic acet-
ylcholine receptor genes may confer an increased risk of
T2D, again suggesting that the nicotinergic system may be
implicated in the pathogenesis of T2D [15]. In this con-
text it is noteworthy that functional nicotinic receptors have
been demonstrated on pancreatic beta cells [27].
Third, we found an inverse linear relationship between pre-
valence of pre-diabetes and time since smoking cessation
among past smokers, suggesting that the adverse effects
of smoking on glucose metabolism may be reversible. Al-
though the individual risk estimates were not statistically
significant, our data suggest that the excess risk of pre-
diabetes is no longer visible among those who stopped
smoking four or more years earlier, supporting the benefi-
cial effect of smoking cessation. These data are consistent
with several earlier reports [11, 12]. However, in at least
one prior study the risk of T2D increased in the first three
years after smoking cessation and declined much slower
thereafter compared with the current study [10]. It was hy-
pothesised that this higher risk might be due to an increase
in body weight after smoking cessation and this effect may
be stronger in older individuals with a higher cumulat-
ive exposure to tobacco smoke. These differential findings
may also suggest that nicotine induced changes in glucose
homeostasis become much more difficult to reverse over
time [10, 12]. If this hypothesis is confirmed in future stud-
ies, it would be another strong motivation to advocate early
smoking cessation and primary smoking prevention.
Strengths and limitations
Strengths of this study include its population based design,
and the availability of a large sample of well-characterised
young and healthy adults with a relatively short exposure
history to environmental confounders. Potential limitations
that should be considered in the interpretation of this study
are the following: First, we enrolled mainly white adults
in our study and the generalisability to other population
groups is uncertain. Second, this is a cross-sectional ana-
lysis, precluding inference of causality to the observed as-
sociations. Third, although our comprehensive dataset is
very complete, there are some missing values for several
covariates, such that the number of individuals slightly var-
ies for individual analyses.
Conclusion
In this large sample of young and healthy individuals, cur-
rent smoking was strongly related to pre-diabetes. Accu-
mulating as few as 5–10 pack-years of smoking carried a
nearly 2-fold increased odds of having pre-diabetes, even
after multivariable adjustment. These data suggest that hy-
perglycaemia is an early event among smokers which oc-
curs independent of other potential confounders, and may
be reversible upon smoking cessation. These data therefore
reinforce the importance of both prevention of smoking ini-
tiation and early smoking cessation. Finally, our data show
an intriguing relationship between nicotine dependence and
prediabetes, suggesting that alterations in the nicotiner-
gic system could be responsible for the hyperglycaemic
changes observed among smokers. Because of the cross-
sectional method, assumptions about the causality of the
mentioned relationships are not possible. To prove causal-
ity of the results and to get a better understanding of the un-
derlying mechanisms of those relationships further invest-
igations are needed.
Funding / potential competing interests: The GAPP study
was supported by the Liechtenstein Government, the Swiss
Heart Foundation, the Swiss Society of Hypertension, the
University of Basel, the University Hospital Basel, the Hanela
Foundation, Schiller AG and Novartis. David Conen was
supported by a grant of the Swiss National Science Foundation
(PP00P3_133681)
Correspondence: David Conen, MD, MPH, Department of
Medicine, University hospital Basel, Petersgraben 4, CH-4031
Basel, Switzerland, david.conen[at]usb.ch
References
1 Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H,
et al. A comparative risk assessment of burden of disease and injury
attributable to 67 risk factors and risk factor clusters in 21 regions,
1990–2010: a systematic analysis for the Global Burden of Disease
Study 2010. Lancet. 2013;380(9859):2224–60.
2 Pirie K, Peto R, Reeves GK, Green J, Beral V. Million Women Study
C. The 21st century hazards of smoking and benefits of stopping:
a prospective study of one million women in the UK. Lancet.
2013;381(9861):133–41.
3 Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to
smoking: 50 years’ observations on male British doctors.
BMJ. 2004;328(7455):1519.
4 Thun M, Carter B, Feskanich D, Freedman N, Prentice R, Lopez AD, et
al. 50–Year Trends in Smoking-Related Mortality in the United States.
N Engl J Med. 2013;368(4):351–64.
5 Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Ander-
son RN, et al. 21st-century hazards of smoking and benefits of cessation
in the United States. N Engl J Med. 2013;368(4):341–50.
6 Houston TK PS, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. Active
and passive smoking and development of glucose intolerance among
young adults in a prospective cohort: CARDIA study. BMJ.
2006;6(332):1064–69.
Original article Swiss Med Wkly. 2014;144:w14019
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 6 of 10
7 Wannamethee SG SA, Perry IJ. Smoking as a modifiable risk factor for
type 2 diabetes in middle-aged men. British Regional Heart Study. Dia-
betes care. 2001;24:1590–95.
8 Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking
and the risk of type 2 diabetes: a systematic review and meta-analysis.
JAMA. 2007;298(22):2654–64.
9 Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH. A prospect-
ive study of cigarette smoking and the incidence of diabetes mellitus
among US male physicians. Ann Intern Med. 2000;109(7):538–42.
10 Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking,
smoking cessation, and risk for type 2 diabetes mellitus: a cohort study.
Ann Intern Med. 2010;152(1):10–7.
11 Hur NW, Kim HC, Nam CM, Jee SH, Lee HC, Suh I. Smoking cessation
and risk of type 2 diabetes mellitus: Korea Medical Insurance Corpora-
tion Study. Eur J Cardiovasc Prev Rehabil. 2007;14(2):244–9.
12 Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette
smoking and diabetes mellitus: evidence of a positive association from
a large prospective cohort study. Int J Epidemiol. 2001;30(3):540–6.
13 Patja K, Jousilahti P, Hu G, Valle T, Qiao Q, Tuomilehto J. Effects of
smoking, obesity and physical activity on the risk of type 2 diabetes
in middle-aged Finnish men and women. J Intern Med.
2005;258(4):356–62.
14 Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking
for body weight, body fat distribution, and insulin resistance. Am J Clin
Nutr. 2008;87(4):801–9.
15 Yang J, Zhu Y, Cole SA, Haack K, Zhang Y, Beebe LA, et al. A gene-
family analysis of 61 genetic variants in the nicotinic acetylcholine re-
ceptor genes for insulin resistance and type 2 diabetes in American In-
dians. Diabetes. 2012;61(7):1888–94.
16 Conen D, Schon T, Aeschbacher S, Pare G, Frehner W, Risch M, et al.
Genetic and phenotypic determinants of blood pressure and other cardi-
ovascular risk factors (GAPP). Swiss Med Wkly. 2013;143:w13728.
17 Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fager-
strom Test for Nicotine Dependence: a revision of the Fagerstrom Tol-
erance Questionnaire. Br J Addict. 1991;86(9):1119–27.
18 American Diabetes Association. Standards of medical care in dia-
betes-2012. Diabetes care. 2012;35Suppl1:S11–63.
19 Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML,
Ainsworth BE, et al. International physical activity questionnaire:
12–country reliability and validity. Med Sci Sports Exerc.
2003;35(8):1381–95.
20 Storr CL, Reboussin BA, Anthony JC. The Fagerstrom test for nicotine
dependence: a comparison of standard scoring and latent class analysis
approaches. Drug Alcohol Depend. 2005;80(2):241–50.
21 Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and
its assessment. Ear Nose Throat J. 1990;69(11):763–5.
22 Bergman BC, Perreault L, Hunerdosse D, Kerege A, Playdon M, Samek
AM, et al. Novel and Reversible Mechanisms of Smoking-Induced In-
sulin Resistance in Humans. Diabetes. 2012.
23 Lee TC, Glynn RJ, Pena JM, Paynter NP, Conen D, Ridker PM, et al.
Socioeconomic status and incident type 2 diabetes mellitus: data from
the Women's Health Study. PLoS One. 2011;6(12):14.
24 Conen D, Glynn RJ, Ridker PM, Buring JE, Albert MA. Socioeconomic
status, blood pressure progression, and incident hypertension in a pro-
spective cohort of female health professionals. Eur Heart J.
2009;30(11):1378–84.
25 Eliasson B, Taskinen MR, Smith U. Long-term use of nicotine gum
is associated with hyperinsulinemia and insulin resistance. Circulation.
1996;94(5):878–81.
26 Liu T, Chen WQ, David SP, Tyndale RF, Wang H, Chen YM, et al. Inter-
action between heavy smoking and CYP2A6 genotypes on type 2 dia-
betes and its possible pathways. Eur J Endocrinol. 2011;165(6):961–7.
27 Yoshikawa H, Hellstrom-Lindahl E, Grill V. Evidence for functional
nicotinic receptors on pancreatic beta cells. Metabolism.
2005;54(2):247–54.
Original article Swiss Med Wkly. 2014;144:w14019
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 7 of 10
Figures (large format)
Figure 1
Recruitment of the GAPP cohort study. Flow chart of the recruitment of the GAPP study.
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Figure 2
Relationship of pre-diabetes with cumulative smoking exposure. Never smokers represent the reference group. Boxes indicate odds ratios,
whiskers are 95% confidence intervals. Data are adjusted for age, sex, Body Mass Index, hypertension, alcohol consumption, education, low
density lipoprotein and high density lipoprotein cholesterol, physical activity, fruit/vegetable consumption and body composition.
Figure 3
Relationship of pre-diabetes with time since smoking cessation.
Never smokers represent the reference group. Boxes indicate odds ratios, whiskers are 95% confidence intervals. Data are adjusted for age,
sex, Body Mass Index, hypertension, alcohol consumption, education, low density lipoprotein and high density lipoprotein cholesterol, physical
activity, fruit/vegetable consumption and body composition.
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Figure 4
Relationship between nicotine dependence and pre-diabetes Data are with (left side) and without (right side) including information on cumulative
smoking exposure into the score. Never smokers represent the reference group. Boxes indicate odds ratios, whiskers are 95% confidence
intervals adjusted for age, sex, Body Mass Index, hypertension, alcohol consumption, education, low density lipoprotein and high density
lipoprotein cholesterol, physical activity, fruit/vegetable consumption and body composition.
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